(Q33807651)

29 July 2017

1 reference

title

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries (English)

1 reference

29 July 2017

1 reference

1

Hilleman MR

1 reference

PubMed ID

10618541

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

18

1 reference

29 July 2017

1436-1447

1 reference

29 July 2017

15

1 reference

Six decades of vaccine development--a personal history

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Joseph-Alexandre Auzias-Turenne, Louis Pasteur, and early concepts of virulence, attenuation, and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Laboratory studies on the 1950 outbreak of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

New antigenic variant in Far East influenza epidemic, 1957.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Status report on adenoviruses and Asian influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Antibody response in volunteers to Asian influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Recovery of new agent from patients with acute respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Pneumococcus: the first one hundred years.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Haemophilus influenzae type b polysaccharide-protein conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

The vacuolating virus, S.V. 40

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Studies of live attenuated measles virus vaccine in man. I. Clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Live, attenuated rubella-virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Protection against Marek's Disease by Vaccination with a Herpesvirus of Turkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Marek's disease vaccine: its implications in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Recovery of Hepatitis Agents in the Marmoset from Human Cases Occurring in Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Etiologic relationship of marmoset-propagated CR326 hepatitis A virus to hepatitis in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Identification of two flavivirus-like genomes in the GB hepatitis agent

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Hepatitis and hepatitis A vaccine: a glimpse of history.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

An Inactivated Hepatitis A Virus Vaccine Prepared from Infected Marmoset Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

New findings in live, attenuated hepatitis A vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Purified and inactivated human hepatitis B vaccine: progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

The current status of the rotavirus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Dendritic cells: a link between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

Multi-epitope DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900434-X

7 January 2021

10.1016/S0264-410X(99)00434-X

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10618541